Literature DB >> 7734001

Efficacy of antibiotic-coated catheters in preventing subcutaneous Staphylococcus aureus infection in rabbits.

R J Sherertz1, W A Carruth, A A Hampton, M P Byron, D D Solomon.   

Abstract

Vascular catheters coated with antiinfective compounds were evaluated as to their ability to prevent Staphylococcus aureus catheter infection in a rabbit model. Zones of inhibition of agar surface-plated S. aureus demonstrated the following hierarchy: dicloxacillin and clindamycin were each better than fusidic acid or chlorhexidine, which were better than ciprofloxacin, cefotaxime, or cefuroxime. In vivo half-lives of inhibitory activity for clindamycin and dicloxacillin were 5.6 and 17.7 h, respectively, with apparent first-order kinetics. Chlorhexidine disappeared in vivo with apparent two-compartment kinetics: first-compartment t1/2, 16.8 h; second-compartment t1/2, 115.6 h. In a rabbit model, dicloxacillin, clindamycin, fusidic acid, and chlorhexidine decreased the risk of infection compared with uncoated control catheters (P < .05). For dicloxacillin, clindamycin, and chlorhexidine, this was true even if the S. aureus inoculation was delayed 48 or 96 h after catheter implantation. These data suggest that vascular catheters with antiinfective coatings should be investigated further in hospitalized patients.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 7734001     DOI: 10.1093/infdis/167.1.98

Source DB:  PubMed          Journal:  J Infect Dis        ISSN: 0022-1899            Impact factor:   5.226


  22 in total

Review 1.  Prevention of infections caused by central venous catheters--established and novel measures.

Authors:  A Bach
Journal:  Infection       Date:  1999       Impact factor: 3.553

2.  Catheter-Related Bloodstream Infection.

Authors: 
Journal:  Curr Infect Dis Rep       Date:  1999-08       Impact factor: 3.725

3.  Durability of anti-infective effect of long-term silicone sheath catheters impregnated with antimicrobial agents.

Authors:  R K Tcholakian; I I Raad
Journal:  Antimicrob Agents Chemother       Date:  2001-07       Impact factor: 5.191

4.  In vitro potency and in vivo efficacy of a novel bis-indole antimicrobial compound in reducing catheter colonization.

Authors:  Mohammad D Mansouri; Timothy J Opperman; John D Williams; Charles Stager; Rabih O Darouiche
Journal:  Antimicrob Agents Chemother       Date:  2012-01-23       Impact factor: 5.191

Review 5.  Infections associated with medical devices: pathogenesis, management and prophylaxis.

Authors:  Christof von Eiff; Bernd Jansen; Wolfgang Kohnen; Karsten Becker
Journal:  Drugs       Date:  2005       Impact factor: 9.546

6.  Fibronectin-binding protein B (FnBPB) from Staphylococcus aureus protects against the antimicrobial activity of histones.

Authors:  Giampiero Pietrocola; Giulia Nobile; Mariangela J Alfeo; Timothy J Foster; Joan A Geoghegan; Vincenzo De Filippis; Pietro Speziale
Journal:  J Biol Chem       Date:  2019-01-08       Impact factor: 5.157

7.  2-O-Sulfated Domains in Syndecan-1 Heparan Sulfate Inhibit Neutrophil Cathelicidin and Promote Staphylococcus aureus Corneal Infection.

Authors:  Atsuko Hayashida; Shiro Amano; Richard L Gallo; Robert J Linhardt; Jian Liu; Pyong Woo Park
Journal:  J Biol Chem       Date:  2015-04-30       Impact factor: 5.157

8.  The Sbi protein is a multifunctional immune evasion factor of Staphylococcus aureus.

Authors:  Emma Jane Smith; Livia Visai; Steven W Kerrigan; Pietro Speziale; Timothy J Foster
Journal:  Infect Immun       Date:  2011-06-27       Impact factor: 3.441

9.  Prolonged antimicrobial activity of a catheter containing chlorhexidine-silver sulfadiazine extends protection against catheter infections in vivo.

Authors:  S Bassetti; J Hu; R B D'Agostino; R J Sherertz
Journal:  Antimicrob Agents Chemother       Date:  2001-05       Impact factor: 5.191

10.  Fibronectin-binding protein B variation in Staphylococcus aureus.

Authors:  Fiona M Burke; Niamh McCormack; Simonetta Rindi; Pietro Speziale; Timothy J Foster
Journal:  BMC Microbiol       Date:  2010-06-01       Impact factor: 3.605

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.